老年人阿司匹林使用与结直肠癌风险
校正其他风险因素后,规律使用阿司匹林与70岁及以上结直肠癌风险显著降低相关(HR 0.80,95%CI 0.72-0.90),但该负相关仅见于70岁前开始使用阿司匹林者(HR 0.80,95%CI 0.67-0.95),70岁后起始使用无显著关联(HR 0.92,95%CI 0.76-1.11)。
要点
- 70岁前开始并持续使用阿司匹林者结直肠癌风险降低(HR 0.80)。
- 70岁后起始使用阿司匹林未显著降低结直肠癌风险(HR 0.92)。
- 老年人启动阿司匹林预防结直肠癌需权衡获益与风险。
核心结论
- 在70岁及以上老年人中,70岁后起始使用阿司匹林与结直肠癌风险降低无显著关联。
- 70岁前开始使用阿司匹林并持续至70岁以后者结直肠癌风险降低。
研究设计与样本
- 汇总分析美国护士健康研究(1980年6月1日至2014年6月30日)和卫生专业人员随访研究(1986年1月1日至2014年1月31日)。
- 排除任何癌症(非黑色素瘤皮肤癌除外)或炎症性肠病诊断者。
- 使用Cox比例风险模型计算多变量校正风险比(HR)和95%置信区间(CI)。
主要发现
- 校正其他风险因素后,规律使用阿司匹林与70岁及以上结直肠癌风险显著降低相关(HR 0.80;95%CI 0.72-0.90)。
- 该负相关仅见于70岁前开始使用阿司匹林者(HR 0.80;95%CI 0.67-0.95)。
- 70岁后起始使用阿司匹林与结直肠癌风险降低无显著关联(HR 0.92;95%CI 0.76-1.11)。
临床怎么用
- 对于70岁及以上老年人,不应为预防结直肠癌而新启动阿司匹林。
- 70岁前已开始规律使用阿司匹林并持续至70岁以后者,可能与结直肠癌风险降低相关。
局限性
- 研究为观察性队列汇总分析,不能证明因果关系。
- 参与者以白人为主(白人女性97.1%,白人男性96.0%),结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Although aspirin is recommended for the prevention of colorectal cancer (CRC) among adults aged 50 to 59 years, recent data from a randomized clinical trial suggest a lack of benefit and even possible harm among older adults. OBJECTIVE: To examine the association between aspirin use and the risk of incident CRC among older adults. DESIGN, SETTING, AND PARTICIPANTS: A pooled analysis was conducted of 2 large US cohort studies, the Nurses' Health Study (June 1, 1980-June 30, 2014) and Health Professionals Follow-up Study (January 1, 1986-January 31, 2014). A total of 94 540 participants aged 70 years or older were included and followed up to June 30, 2014, for women or January 31, 2014, for men. Participants with a diagnosis of any cancer, except nonmelanoma skin cancer, or inflammatory bowel disease were excluded. Statistical analyses were conducted from December 2019 to October 2020. MAIN OUTCOMES AND MEASURES: Cox proportional hazards models were used to calculate multivariable adjusted hazard ratios (HRs) and 95% CIs for incident CRC. RESULTS: Among the 94 540 participants (mean [SD] age, 76.4 [4.9] years for women, 77.7 [5.6] years for men; 67 223 women [71.1%]; 65 259 White women [97.1%], 24 915 White men [96.0%]) aged 70 years or older, 1431 incident cases of CRC were documented over 996 463 person-years of follow-up. After adjustment for other risk factors, regular use of aspirin was associated with a significantly lower risk of CRC at or after age 70 years compared with nonregular use (HR, 0.80; 95% CI, 0.72-0.90). However, the inverse association was evident only among aspirin users who initiated aspirin use before age 70 years (HR, 0.80; 95% CI, 0.67-0.95). In contrast, initiating aspirin use at or after 70 years was not significantly associated with a lower risk of CRC (HR, 0.92; 95% CI, 0.76-1.11). CONCLUSIONS AND RELEVANCE: Initiating aspirin at an older age was not associated with a lower risk of CRC in this pooled analysis of 2 cohort studies. In contrast, those who used aspirin before age 70 years and continued into their 70s or later had a reduced risk of CRC.
引用
- Guo CG, Ma W, Drew DA, et al. Aspirin Use and Risk of Colorectal Cancer Among Older Adults. JAMA Oncol. 2021. PMID: 33475710. doi:10.1001/jamaoncol.2020.7338
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。